Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA).

Manic-depressive illness is a serious psychiatric disorder that in many, but far from all, patients can be treated with lithium. The main causes for discontinuation of lithium therapy are unpleasant or serious side effects and lack of response. The reason for the striking variation in clinical efficacy of lithium treatment among bipolar patients is not known. The enzyme myo-inositol monophosphatase (IMPase) has been postulated as a target for the mood-stabilizing effects of lithium, but variation in the coding region of the human IMPA gene encoding IMPase activity has not been observed in manic-depressive patients (Steen et al., Pharmacogenetics, 1996, 6, 113-116). It is nevertheless conceivable that polymorphisms or mutations in the noncoding regions of this gene could influence the lithium response in psychiatric patients. As a first step in investigating this possibility, we here report the genomic structure of the human IMPA gene. The gene is composed of at least nine exons and covers more than 20 kb of sequence on chromosome 8q21.13-q21.3. In the 3'-untranslated part of the gene, we observed a polymorphism (a G to A transition) and also two short sequences similar to the inositol/cholin-responsive element consensus. Finally, we postulate that two additional IMPA-like transcripts originate from the human genome, one from a position close to IMPA itself on chromosome 8 and the other from chromosome 18p. Our data may contribute to the identification of genetic factors involved in the pathogenesis and determination of treatment response in manic-depressive illness.

[1]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[2]  N. Freimer,et al.  A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Deloukas,et al.  A Gene Map of the Human Genome , 1996, Science.

[4]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Botstein,et al.  A manic depressive history , 1996, Nature Genetics.

[6]  P. V. van Haastert,et al.  Dictyostelium discoideum contains three inositol monophosphatase activities with different substrate specificities and sensitivities to lithium. , 1996, The Biochemical journal.

[7]  V. Steen,et al.  Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness. , 1996, Pharmacogenetics.

[8]  A. Molven,et al.  Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of human cytochrome P450 CYP2D6 gene. , 1995, Human molecular genetics.

[9]  E. Schweizer,et al.  DNA binding site of the yeast heteromeric Ino2p/Ino4p basic helix‐loop‐helix transcription factor: structural requirements as defined by saturation mutagenesis , 1995, FEBS letters.

[10]  S. Pollack,et al.  Inositol monophosphatase — a putative target for Li+ in the treatment of bipolar disorder , 1995, Trends in Neurosciences.

[11]  J. Sikela,et al.  Gene–based sequence–tagged–sites (STSs) as the basis for a human gene map , 1995, Nature Genetics.

[12]  H. Manji,et al.  Signal transduction pathways. Molecular targets for lithium's actions. , 1995, Archives of general psychiatry.

[13]  M. Stoffel,et al.  Human fructose-1,6-bisphosphatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2-q22.3, and mutation screening in subjects with fructose-1,6-bisphosphatase deficiency. , 1995, Genomics.

[14]  S. Pollack,et al.  Structure and mechanism of inositol monophosphatase , 1995, FEBS letters.

[15]  C. Nemeroff,et al.  The American Psychiatric Press Textbook of Psychopharmacology , 1995 .

[16]  J. Springer,et al.  Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis. , 1995, Biochemistry.

[17]  J. Springer,et al.  Structural analysis of inositol monophosphatase complexes with substrates. , 1995, Biochemistry.

[18]  E. Schweizer,et al.  Yeast transcriptional activator INO2 interacts as an Ino2p/Ino4p basic helix-loop-helix heteromeric complex with the inositol/choline-responsive element necessary for expression of phospholipid biosynthetic genes in Saccharomyces cerevisiae. , 1995, Nucleic acids research.

[19]  L. L. Iversen,et al.  Mechanism of inositol monophosphatase, the putative target of lithium therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Nurnberger,et al.  Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Lipscomb,et al.  Structural similarities between fructose-1,6-bisphosphatase and inositol monophosphatase. , 1993, Biochemical and biophysical research communications.

[22]  F. J. Bailey,et al.  cDNA cloning of human and rat brain myo-inositol monophosphatase. Expression and characterization of the human recombinant enzyme. , 1992, The Biochemical journal.

[23]  G. Gonnet,et al.  Exhaustive matching of the entire protein sequence database. , 1992, Science.

[24]  A. Hahn,et al.  Coordinate genetic control of yeast fatty acid synthase genes FAS1 and FAS2 by an upstream activation site common to genes involved in membrane lipid biosynthesis. , 1992, The EMBO journal.

[25]  A. F. Neuwald,et al.  Diverse proteins homologous to inositol monophosphatase , 1991, FEBS letters.

[26]  J. Lopes,et al.  Interaction of trans and cis regulatory elements in the INO1 promoter of Saccharomyces cerevisiae. , 1991, Nucleic acids research.

[27]  L. F. Engebretsen,et al.  Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. , 1991, Nucleic acids research.

[28]  Michael J. Berridge,et al.  Neural and developmental actions of lithium: A unifying hypothesis , 1989, Cell.

[29]  M. Baudis,et al.  Modification of enzymatically amplified DNA for the detection of point mutations. , 1989, Nucleic acids research.

[30]  G. Agam,et al.  Inositol-1-phosphatase of human erythrocytes is inhibited by therapeutic lithium concentrations , 1989, Psychiatry Research.

[31]  W. Blackwood.  Chromosome 18 DNA markers and manic-depressive illness : evidence for a susceptibility gene , 1994 .

[32]  F. Goodwin.  Manic-Depressive Illness , 1990 .